BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/151020 |
Resumo: | Funding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Publisher Copyright: © 2022 The Author(s) |
id |
RCAP_d0e2726d55eb854ed9c5b79bc7caacce |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/151020 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIsdesign and rationale of the BASELINE trialCardiology and Cardiovascular MedicineFunding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Publisher Copyright: © 2022 The Author(s)Background: Surgical aortic valve bioprostheses may degenerate over time and require redo intervention. Transcatheter aortic valve replacement (TAVR) is a less invasive alternative to redo surgery. The BAlloon Expandable vs. SElf Expanding Transcatheter VaLve for Degenerated BioprosthesIs (BASELINE) trial was designed to compare the performance of the balloon-expandable SAPIEN-3 Ultra and the self-expanding EVOLUT PRO+ valve systems in symptomatic patients with a failing surgical bioprosthesis. Methods: The BASELINE trial is an investigator-initiated, non-funded, prospective, randomized, open-label, superiority trial enrolling a total of 440 patients in up to 50 sites in 12 countries in Europe and North-America. The primary endpoint is device success at 30-days defined by the Valve Academic Research Consortium-3 Criteria as the composite of technical success, freedom from mortality, freedom for surgery or intervention related to the device or to a major vascular or access-related or cardiac structural complication with an intended performance of the valve (mean gradient <20 mmHg and less than moderate aortic regurgitation). The co-primary endpoint at 1 year is defined as the composite of all-cause death, disabling stroke, rehospitalization for heart failure or valve related problems. Independent Core Laboratories will conduct uniform analyses of echocardiography (pre-, post-, 1-year post-procedure), multi-sliced computed tomography (pre-, and if available post-procedure) and cine-fluoroscopy studies. Conclusions: The BASELINE trial is a head-to-head comparative trial investigating the 2 most used contemporary transcatheter heart valves for the treatment of a failing surgical aortic bioprosthesis. (ClinicalTrials.gov number NCT04843072).NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNNuis, Rutger Janvan Belle, EricTeles, RuiBlackman, DanielVeulemans, VerenaSantos, Ignacio AmatPilgrim, ThomasTarantini, GiuseppeSaia, FrancescoIakovou, IoannisMascherbauer, JuliaVincent, FlavienGeleijnse, MarcelSathananthan, JanarthananWood, DavidMakkar, RajVan Mieghem, Nicolas M.2023-03-21T22:27:56Z2023-022023-02-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article9application/pdfhttp://hdl.handle.net/10362/151020eng0002-8703PURE: 56515115https://doi.org/10.1016/j.ahj.2022.11.013info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:33:27Zoai:run.unl.pt:10362/151020Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:54:25.366264Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs design and rationale of the BASELINE trial |
title |
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs |
spellingShingle |
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs Nuis, Rutger Jan Cardiology and Cardiovascular Medicine |
title_short |
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs |
title_full |
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs |
title_fullStr |
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs |
title_full_unstemmed |
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs |
title_sort |
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs |
author |
Nuis, Rutger Jan |
author_facet |
Nuis, Rutger Jan van Belle, Eric Teles, Rui Blackman, Daniel Veulemans, Verena Santos, Ignacio Amat Pilgrim, Thomas Tarantini, Giuseppe Saia, Francesco Iakovou, Ioannis Mascherbauer, Julia Vincent, Flavien Geleijnse, Marcel Sathananthan, Janarthanan Wood, David Makkar, Raj Van Mieghem, Nicolas M. |
author_role |
author |
author2 |
van Belle, Eric Teles, Rui Blackman, Daniel Veulemans, Verena Santos, Ignacio Amat Pilgrim, Thomas Tarantini, Giuseppe Saia, Francesco Iakovou, Ioannis Mascherbauer, Julia Vincent, Flavien Geleijnse, Marcel Sathananthan, Janarthanan Wood, David Makkar, Raj Van Mieghem, Nicolas M. |
author2_role |
author author author author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Nuis, Rutger Jan van Belle, Eric Teles, Rui Blackman, Daniel Veulemans, Verena Santos, Ignacio Amat Pilgrim, Thomas Tarantini, Giuseppe Saia, Francesco Iakovou, Ioannis Mascherbauer, Julia Vincent, Flavien Geleijnse, Marcel Sathananthan, Janarthanan Wood, David Makkar, Raj Van Mieghem, Nicolas M. |
dc.subject.por.fl_str_mv |
Cardiology and Cardiovascular Medicine |
topic |
Cardiology and Cardiovascular Medicine |
description |
Funding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Publisher Copyright: © 2022 The Author(s) |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-03-21T22:27:56Z 2023-02 2023-02-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/151020 |
url |
http://hdl.handle.net/10362/151020 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
0002-8703 PURE: 56515115 https://doi.org/10.1016/j.ahj.2022.11.013 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
9 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138133017624576 |